The Molecular Basis of Insomnia: Implication for Therapeutic Approaches.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 427, doi. 10.1002/ddr.21338
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2016 AND VI 77 AND IP 8
Results: 11
1
2
Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 437, doi. 10.1002/ddr.21334
- By:
- Publication type:
- Article
3
Issue Information-TOC.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 425, doi. 10.1002/ddr.21374
- Publication type:
- Article
4
New Horizons in Pediatric Psychopharmacology.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 474, doi. 10.1002/ddr.21333
- By:
- Publication type:
- Article
5
Benefits of Cognitive Treatments Administered to Patients Affected by Mild Cognitive Impairment/Mild Neurocognitive Disorder.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 444, doi. 10.1002/ddr.21339
- By:
- Publication type:
- Article
6
Do Circadian Rhythms Draw the Patterns of Sustained Mental Vigor and Ailment?
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 469, doi. 10.1002/ddr.21342
- By:
- Publication type:
- Article
7
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 479, doi. 10.1002/ddr.21343
- By:
- Publication type:
- Article
8
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 453, doi. 10.1002/ddr.21344
- By:
- Publication type:
- Article
9
Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 489, doi. 10.1002/ddr.21347
- By:
- Publication type:
- Article
10
Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 458, doi. 10.1002/ddr.21368
- By:
- Publication type:
- Article
11
Instruction to Authors.
- Published in:
- Drug Development Research, 2016, v. 77, n. 8, p. 495, doi. 10.1002/ddr.21375
- Publication type:
- Article